Cytodyn Inc (CYDY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 05/31
(Values in U.S. thousands)
| 05-2025 | 05-2024 | 05-2023 | 05-2022 | 05-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 3,745 | -49,841 | -79,824 | -210,820 | -176,465 |
| Depreciation Amortization | 425 | 1,677 | 2,370 | 3,826 | 15,502 |
| Other Working Capital | -16,172 | 11,658 | -1,195 | 68,712 | -20,092 |
| Other Operating Activity | 3,237 | 25,524 | 53,539 | 60,559 | 63,482 |
| Operating Cash Flow | $-8,765 | $-10,982 | $-25,110 | $-77,723 | $-117,573 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | N/A | -122 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $-122 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 0 | 2,011 | 895 | N/A | 100,000 |
| Common Stock Issued | 11,564 | 9,437 | 29,032 | 48,011 | 39,327 |
| Dividend Paid | N/A | N/A | N/A | N/A | -243 |
| Other Financing Activity | -710 | 300 | 0 | 0 | -1,738 |
| Financing Cash Flow | $10,854 | $11,748 | $29,927 | $48,011 | $137,346 |
| Beginning Cash Position | 9,814 | 9,048 | 4,231 | 33,943 | 14,292 |
| End Cash Position | 11,903 | 9,814 | 9,048 | 4,231 | 33,943 |
| Net Cash Flow | $2,089 | $766 | $4,817 | $-29,712 | $19,651 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,765 | -10,982 | -25,110 | -77,723 | -117,573 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -122 |
| Free Cash Flow | -8,765 | -10,982 | -25,110 | -77,723 | -117,695 |